Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classificação em ações #20489
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Preço da ação
$20.33
Valor de mercado
$128.73M
Variação (1 dia)
-1.10%
Variação (1 ano)
80.41%
País
PL
Negociar Captor Therapeutics Spolka Akcyjna (CTX)

Categoria

Histórico de desdobramentos de ações de Captor Therapeutics Spolka Akcyjna (CTX)
As ações Captor Therapeutics Spolka Akcyjna (símbolo: CTX) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 24, 2026.
Uma ação CTX comprada antes de Aug 24, 2026 equivaleria hoje a 0 ações CTX.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH